Document Detail


Platelet antibodies in patients with migraine.
MedLine Citation:
PMID:  9664754     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The reported decrease of platelet serotonin receptors in patients with migraine could be due to an autoimmune reaction. We therefore, examined sera from 42 migraineurs without aura, 26 migraineurs with aura, and 107 headache-free blood donors for platelet-reactive antibodies using the platelet adhesion immunofluorescence test, the NIH-lymphocytotoxicity test, and the monoclonal antibody-specific immobilization of platelet antigens test. IgG antibodies against non-HLA class I platelet antigens were found in 9.5% of patients with migraine without aura, 7.6% of patients with migraine with aura, and in 7.5% of controls; IgM antibodies were found in 11.9% of patients with migraine without aura, in 30.8% of patients with migraine with aura, and in 13.1% of controls. Most antibodies were directed against glycoprotein complexes II-III (fibrinogen receptor) or Ib-IX (thrombin receptor). Two patients with migraine without aura but no patient with migraine with aura nor any control subject had IgG antibodies of unknown specificity. One patient (2.4%) with migraine without aura and two patients (7.7%) with migraine with aura, as well as 2 controls (1.9%) had IgM antibodies not further specified. The differences in frequency of platelet antibodies of antibodies of known or unknown specificity in patients with migraine without aura and migraine with aura and controls were not statistically significant. Therefore, our data do not support the hypothesis of a pathophysiologically relevant autoimmune reaction against platelet serotonin receptors in th majority of patients with migraine. We can not exclude the occurrence of antibodies against neuron-specific serotonin receptors.
Authors:
M Schabet; M Hummler; K Schepelmann; M Schnaidt
Related Documents :
23846224 - Ros-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte...
24102264 - Activated platelet chemiluminescence and presence of cd45+ platelets in patients with a...
23631504 - Nanodiamonds activate blood platelets and induce thromboembolism.
23919774 - Multipotent, permeable drug ass234 inhibits aβ aggregation, possesses antioxidant prop...
6654624 - The tripeptide zami-420 inhibits thromboxane-induced gastric vasoconstriction and ischa...
17110454 - Mtor-dependent synthesis of bcl-3 controls the retraction of fibrin clots by activated ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Headache     Volume:  38     ISSN:  0017-8748     ISO Abbreviation:  Headache     Publication Date:  1998 Jun 
Date Detail:
Created Date:  1998-08-25     Completed Date:  1998-08-25     Revised Date:  2009-02-02    
Medline Journal Info:
Nlm Unique ID:  2985091R     Medline TA:  Headache     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  472-4     Citation Subset:  IM    
Affiliation:
Neurologische Universitätsklinik, Tübingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies / blood*
Blood Platelets / immunology*
Humans
Migraine Disorders / blood*,  immunology*
Platelet Glycoprotein GPIIb-IIIa Complex / immunology*
Platelet Glycoprotein GPIb-IX Complex / immunology*
Receptors, Serotonin / immunology
Chemical
Reg. No./Substance:
0/Antibodies; 0/Platelet Glycoprotein GPIIb-IIIa Complex; 0/Platelet Glycoprotein GPIb-IX Complex; 0/Receptors, Serotonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle te...
Next Document:  Anticephalgic photoprotective premedicated mask. A report of a successful double-blind placebo-contr...